These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17266026)

  • 1. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
    Tait LR; Pauley RJ; Santner SJ; Heppner GH; Heng HH; Rak JW; Miller FR
    Int J Cancer; 2007 May; 120(10):2127-34. PubMed ID: 17266026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
    Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
    Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
    Shekhar MP; Tait L; Pauley RJ; Wu GS; Santner SJ; Nangia-Makker P; Shekhar V; Nassar H; Visscher DW; Heppner GH; Miller FR
    Cancer Biol Ther; 2008 Nov; 7(11):1774-82. PubMed ID: 18787417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
    Chang H; Mohabir N; Done S; Hamel PA
    J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion in breast lesions: the role of the epithelial-stroma barrier.
    Rakha EA; Miligy IM; Gorringe KL; Toss MS; Green AR; Fox SB; Schmitt FC; Tan PH; Tse GM; Badve S; Decker T; Vincent-Salomon A; Dabbs DJ; Foschini MP; Moreno F; Wentao Y; Geyer FC; Reis-Filho JS; Pinder SE; Lakhani SR; Ellis IO
    Histopathology; 2018 Jun; 72(7):1075-1083. PubMed ID: 29197112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
    Wahler J; So JY; Kim YC; Liu F; Maehr H; Uskokovic M; Suh N
    Cancer Prev Res (Phila); 2014 Jun; 7(6):617-26. PubMed ID: 24691501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
    Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
    Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
    Schedin P; Borges V
    Breast Cancer Res; 2009; 11(2):102. PubMed ID: 19344495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?
    Recavarren RA; Chivukula M; Carter G; Dabbs DJ
    Int J Clin Exp Pathol; 2009 Oct; 3(1):87-97. PubMed ID: 19918332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
    Yazhou C; Wenlv S; Weidong Z; Licun W
    Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
    Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
    Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
    Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
    J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.